Jürg Eckhardt
Directeur/Membre du Conseil chez TargeGen, Inc.
Profil
Jürg Eckhardt is currently a Director at TargeGen, Inc. He previously held Director positions at Calypso Medical Technologies, Inc., NeurogesX, Inc., and Anteis SA. He was also the Chairman of Lumavita AG.
Additionally, he worked as a Management Consultant at McKinsey & Co., Inc. and as an Investment Manager at Global Life Science Ventures AG.
He was a Partner at Bellevue Asset Management (Venture Capital) from 2004 to 2016.
Dr. Eckhardt holds an MBA from INSEAD and a doctorate from the University of Basel.
Postes actifs de Jürg Eckhardt
| Sociétés | Poste | Début |
|---|---|---|
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jürg Eckhardt
| Sociétés | Poste | Fin |
|---|---|---|
Bellevue Asset Management (Venture Capital)
 Bellevue Asset Management (Venture Capital) Investment ManagersFinance Bellevue Asset Management (Venture Capital) is the venture capital arm of Bellevue Asset Management AG, a subsidiary of Bellevue Group AG (SW: BBN) headquartered in Zurich, Switzerland. The firm was founded in 1993. | Analyste en capital-investissement | 31/08/2016 |
Lumavita AG
 Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | Président | 07/01/2014 |
Global Life Science Ventures AG
 Global Life Science Ventures AG Investment ManagersFinance Global Life Science Ventures AG (GLSV-Switzerland) is the Swiss office of the independent venture capital firm which was founded in 1996 with the support of Dr. Stefan Engelhorn. One of the first European venture capital firms to focus exclusively on the life science industry, GLSV-Switzerland advises and manages funds for leading European banks, insurance companies, funds-of-funds and family offices. In addition to their office in Zug, the firm has an office in Munich, Germany. The two offices act as one team with a global perspective, concentrating on their German-speaking home markets and pursuing international partnering opportunities, including investments in the US. GLSV-Switzerland is sensitive to investing in companies with technological or bioethical issues which are still the object of public debate and advises potential investee companies to adhere to core ethical values published in official publications. | Private Equity Investor | 01/10/2004 |
swiss smile Holding AG
 swiss smile Holding AG Medical/Nursing ServicesHealth Services swiss smile Holding AG operates as a holding company with interests in operates a chain of dental clinics. It offers treatments in the areas of aesthetic dentistry, bleaching, implantology, orthodontic, oral surgery, endodontic, pediatric dentistry, periodontology, professional teeth cleaning, bad breath, prosthetic, tooth-colored filling, teeth grinding, general anesthetic, and emergency aspects. The firm also provides whitening toothpastes, herbal toothpastes, whitening toothbrushes, soft toothbrushes, waxed dental tapes, and interdental brushes. The company was founded by Haleh Abivardi Brönner and Golnar Abivardi Signer in 2006 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - |
| NEUROGESX, INC | Directeur/Membre du Conseil | - |
Formation de Jürg Eckhardt
| INSEAD | Masters Business Admin |
| University of Basel | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Calypso Medical Technologies, Inc.
 Calypso Medical Technologies, Inc. Medical/Nursing ServicesHealth Services Calypso Medical Technologies, Inc. provided radiation therapy and medical services. The company was founded by Eric R. Meier, Alfred G. Merriweather and Steve Tallman in 1999 and was headquartered in Seattle, WA. | Health Services |
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
NeurogesX, Inc.
 NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology NeurogesX, Inc. developed and commercialized novel pain management therapies. The company was founded by Wendye R. Robbins on May 28, 1998 and was headquartered in San Mateo, CA. | Health Technology |
Global Life Science Ventures AG
Global Life Science Ventures AG Investment ManagersFinance Global Life Science Ventures AG (GLSV-Switzerland) is the Swiss office of the independent venture capital firm which was founded in 1996 with the support of Dr. Stefan Engelhorn. One of the first European venture capital firms to focus exclusively on the life science industry, GLSV-Switzerland advises and manages funds for leading European banks, insurance companies, funds-of-funds and family offices. In addition to their office in Zug, the firm has an office in Munich, Germany. The two offices act as one team with a global perspective, concentrating on their German-speaking home markets and pursuing international partnering opportunities, including investments in the US. GLSV-Switzerland is sensitive to investing in companies with technological or bioethical issues which are still the object of public debate and advises potential investee companies to adhere to core ethical values published in official publications. | Finance |
Lumavita AG
Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | Health Services |
Anteis SA
 Anteis SA Medical/Nursing ServicesHealth Services Anteis SA modifies and functionalizes injectable hyaluronic acid for medical applications. The firm serves in Asthetic dermatology. The company was founded by Gilles Bos Gilles in March 2003 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
swiss smile Holding AG
swiss smile Holding AG Medical/Nursing ServicesHealth Services swiss smile Holding AG operates as a holding company with interests in operates a chain of dental clinics. It offers treatments in the areas of aesthetic dentistry, bleaching, implantology, orthodontic, oral surgery, endodontic, pediatric dentistry, periodontology, professional teeth cleaning, bad breath, prosthetic, tooth-colored filling, teeth grinding, general anesthetic, and emergency aspects. The firm also provides whitening toothpastes, herbal toothpastes, whitening toothbrushes, soft toothbrushes, waxed dental tapes, and interdental brushes. The company was founded by Haleh Abivardi Brönner and Golnar Abivardi Signer in 2006 and is headquartered in Zurich, Switzerland. | Health Services |
Bellevue Asset Management (Venture Capital)
Bellevue Asset Management (Venture Capital) Investment ManagersFinance Bellevue Asset Management (Venture Capital) is the venture capital arm of Bellevue Asset Management AG, a subsidiary of Bellevue Group AG (SW: BBN) headquartered in Zurich, Switzerland. The firm was founded in 1993. | Finance |
